Literature DB >> 23931786

Sensory-motor assessment in clinical research trials.

Joseph C Arezzo1, Shirley Seto, Herbert H Schaumburg.   

Abstract

The assessment of changes in sensory-motor function in clinical research presents a unique set of difficulties. Clinimetrics is the science of measurement as related to the identification of a clinical disorder, the tracing of the progression of the condition under study, and calculation of its impact. The selection of appropriate measures for clinical studies of sensory-motor function must consider validity, sensitivity, specificity, responsiveness, reliability, and feasibility. Reasonable measures of motor function in clinical research include manual examination of muscle strength, electrophysiology, functional scales, patient-reported outcomes (e.g., quality of life), and for severe conditions such as ALS, survival. The assessment of sensory function includes targeted electrophysiology and QOL, as well as more focused measures such as quantitative sensory testing and the scoring of positive symptoms. Each individual measure and each combination of endpoints has its strengths and limitations.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALS functional rating scale; Clinical trials of neuropathy; assessment of sensory-motor function; clinimetrics; electrophysiology; patient-reported outcome measures; quantitative sensory testing

Mesh:

Year:  2013        PMID: 23931786     DOI: 10.1016/B978-0-444-52902-2.00016-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

1.  Validity of range of motion, muscle strength, sensitivity, and Tinel sign tele-assessment in adults with traumatic brachial plexus injury.

Authors:  Andreia Gushikem; Rodrigo Rodrigues Gomes Costa; Ana Lucia Lima Cabral; Luis Fernando Lopes Bomtempo; Marcio de Mendonça Cardoso
Journal:  Acta Neurochir (Wien)       Date:  2022-03-28       Impact factor: 2.816

2.  Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.

Authors:  Daniel L Hertz; Kouros Owzar; Sherrie Lessans; Claudia Wing; Chen Jiang; William Kevin Kelly; Jai Patel; Susan Halabi; Yoichi Furukawa; Heather E Wheeler; Alexander B Sibley; Cameron Lassiter; Lois Weisman; Dorothy Watson; Stefanie D Krens; Flora Mulkey; Cynthia L Renn; Eric J Small; Phillip G Febbo; Ivo Shterev; Deanna L Kroetz; Paula N Friedman; John F Mahoney; Michael A Carducci; Michael J Kelley; Yusuke Nakamura; Michiaki Kubo; Susan G Dorsey; M Eileen Dolan; Michael J Morris; Mark J Ratain; Howard L McLeod
Journal:  Clin Cancer Res       Date:  2016-05-03       Impact factor: 12.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.